Live Breaking News & Updates on Myotonic Dystrophy

Stay updated with breaking news from Myotonic dystrophy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Boy, 6, given trip to Disney World through Make-A-Wish Foundation

The owner of Thorn Hill Tap House, Marc Teklinski, donates a portion of sales to the Make-A-Wish Foundation. ....

Marc Teklinski , Sean Hopkins , Decker Hopkins , Disney World , North Hills , Thorn Hill Tap House , Decker Hopkins , Thorn Hill Tap House , Marc Teklinski , Myotonic Dystrophy , Makea Wish Foundation ,

Design Therapeutics (NASDAQ:DSGN) Downgraded to Neutral at Piper Sandler

Design Therapeutics (NASDAQ:DSGN – Get Free Report) was downgraded by investment analysts at Piper Sandler from an “overweight” rating to a “neutral” rating in a note issued to investors on Tuesday, Briefing.com reports. They currently have a $6.00 target price on the stock, down from their previous target price of $42.00. Piper Sandler’s price target […] ....

Nova Scotia , Deepa Prasad , Piper Sandler , Rodneyw Lappe , Leerink Partnrs , Design Therapeutics Inc , York Mellon Corp , Royal Bank , Blackrock Inc , Jpmorgan Chase Co , Metlife Investment Management , Design Therapeutics , Get Free Report , Director Rodney , Director Deepa Prasad , New York Mellon Corp , Life Investment Management , Friedreich Ataxia , Myotonic Dystrophy , Design Therapeutics Daily , Nasdaq Dsgn ,

Chikungunya Pipeline Analysis (2023) Covering Clinical

Chikungunya Pipeline Analysis (2023) Covering Clinical
openpr.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from openpr.com Daily Mail and Mail on Sunday newspapers.

Myotonic Dystrophy ,

Brokerages Set Design Therapeutics, Inc. (NASDAQ:DSGN) PT at $6.20

Shares of Design Therapeutics, Inc. (NASDAQ:DSGN – Get Free Report) have earned a consensus rating of “Hold” from the six research firms that are covering the company, MarketBeat Ratings reports. Six investment analysts have rated the stock with a hold rating. The average twelve-month price objective among analysts that have covered the stock in the […] ....

New Zealand General , New Zealand , Leerink Partnrs , Deepa Prasad , Rodneyw Lappe , Design Therapeutics Company Profile , Design Therapeutics Inc , Wellington Management Group , Blackrock Inc , Vanguard Group Inc , Avoro Capital Advisors , Securities Exchange Commission , Royal Bank , Design Therapeutics , Get Free Report , Marketbeat Ratings , Director Rodney , Exchange Commission , Director Deepa Prasad , Capital Advisors , Management Group , State Street Corp , Street Corp , Get Free , Friedreich Ataxia , Myotonic Dystrophy ,

Harmony Biosciences Reports Strong Third Quarter 2023 Financial Results

Continued Strong Growth with WAKIX® Net Revenue of $160.3 Million for Third Quarter 2023; Increased ~37% Year-over-Year Average Number of Patients on WAKIX Increased by ~350 Sequentially to ~5,800. ....

United Kingdom , United States , Jeffreym Dayno , Luis Sanay , Company Updates , Harmony Biosciences Holdings Inc , Drug Administration , Paragon Biosciences , Zynerba Pharmaceuticals , Company Nasdaq , European Union , Acquisition Of Zynerba Pharmaceuticals , Exchange Commission , Million Share Repurchase Program , Continued Strong Growth , Net Revenue , Third Quarter , Pursue Idiopathic Hypersomnia Indication , Next Step , Full Data Set , Diversified Pipeline , Pivotal Phase , Common Stock , Directors Authorized New , Share Repurchase , Held Today ,